| 國立成功大學 |
2021-05 |
Inhibition of beta-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice
|
Hsieh;Mei-Jen;Weng;Ching-Chieh;Lin;Yu-Chun;Wu;Chia-Chen;Chen;Li-Tzong;Cheng;Kuang-Hung |
| 國立成功大學 |
2021-04-12 |
An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan
|
Chang;Jeffrey, S.;Chen;Li-Tzong;Shan;Yan-Shen;Chu;Pei-Yi;Tsai;Chia-Rong;Tsai;Hui-Jen |
| 國立成功大學 |
2021-03-1 |
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors
|
Tsai;Hui-Jen;Shiah;Her-Shyong;Chang;Jang-Yang;Su;Wu-Chou;Chiang;Nai-Jung;Chen;Li-Tzong |
| 國立成功大學 |
2020-12-29 |
Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan
|
Chen;Chia-Yu;Liang;Shih-Hsin;Su;Yung-Yeh;Chiang;Nai-Jung;Wang;Hui-Ching;Chiu;Chang-Fang;Chen;Li-Tzong;Bai;Li-Yuan |
| 國立成功大學 |
2020-05-4 |
The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort
|
Su;Yung-Yeh;Chiang;Nai-Jung;Tsai;Hui-Jen;Yen;Chia-Jui;Shan;Yan-Shen;Chen;Li-Tzong |
| 國立成功大學 |
2019-12-26 |
Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia
|
Lin;Wen-Hsing;Wu;Su-Ying;Yeh;Teng-Kuang;Chen;Chiung-Tong;Song;Jen-Shin;Shiao;Hui-Yi;Kuo;Ching-Chuan;Hsu;Tsu;Lu;Cheng-Tai;Wang;Pei-Chen;Wu;Tsung-Sheng;Peng;Yi-Hui;Lin;Hui-You;Chen;Ching-Ping;Weng;Ya-Ling;Kung;Fang-Chun;Wu;Mine-Hsine;Su;Yu-Chieh;Huang;Kuo-Wei;Chou;Ling-Hui;Hsueh;Ching-Cheng;Yen;Kuei-Jung;Kuo;Po-Chu;Huang;Chen-Lung;Chen;Li-Tzong;Shih;Chuan;Tsai;Hui-Jen;Jiaang;Weir-Torn |
| 國立成功大學 |
2019-09-19 |
Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors
|
Hsueh;Yuan-Shuo;Chang;Hua, Hui;Shan;Yan-Shen;Sun;Sunny, H.;Fletcher;Alfred, Jonathan;Li;Chien-Feng;Chen;Li-Tzong |
| 國立成功大學 |
2019-08 |
Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer
|
Chen;Li-Tzong;Macarulla;Teresa;Blanc;Jean-Frederic;Mirakhur;Beloo;Jong, de;Floris, A.;Belanger;Bruce;Bekaii-Saab;Tanios;Siveke;Jens, T. |
| 國立成功大學 |
2019-06-28 |
Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol
|
Chen;Shang-Hung;Tsai;Hsiang-Lin;Jiang;Jeng-Kai;Sung;Yung-Chuan;Huang;Ching-Wen;Yeh;Yu-Min;Chen;Li-Tzong;Wang;Jaw-Yuan |
| 國立成功大學 |
2019 |
Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8
|
Wang;Hao-Chen;Lin;Yung-Lun;Hsu;Ching-Cheng;Chao;Ying-Jui;Hou;Ya-Chin;Chiu;Tai-Jan;Huang;Po-Hsien;Tang;Ming-Jer;Chen;Li-Tzong;Shan;Yan-Shen |
| 國立成功大學 |
2017-11-28 |
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors
|
Chu;Pei-Yi;Jiang;Sheng, Shih;Shan;Yan-Shen;Hung;Wen-Chun;Chen;Ming-Huang;Lin;Hui-You;Chen;Yu-Lin;Tsai;Hui-Jen;Chen;Li-Tzong |
| 國立成功大學 |
2017-11-17 |
The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors
|
Chang;Tsung-Ming;Shan;Yan-Shen;Chu;Pei-Yi;Jiang;Sheng, Shih;Hung;Wen-Chun;Chen;Yu-Lin;Tu;Hsiu-Chi;Lin;Hui-You;Tsai;Hui-Jen;Chen;Li-Tzong |
| 國立成功大學 |
2017-09-12 |
A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients
|
Tsai;Hui-Jen;Jiang;Sheng, Shih;Hung;Wen-Chun;Borthakur;Gautam;Lin;Sheng-Fung;Pemmaraju;Naveen;Jabbour;Elias;Bomalaski;John, S.;Chen;Ya-Ping;Hsiao;Hui-Hua;Wang;Ming-Chung;Kuo;Ching-Yuan;Chang;Hung;Yeh;Su-Peng;Cortes;Jorge;Chen;Li-Tzong;Chen;Tsai-Yun |
| 高雄醫學大學 |
2003 |
胃腸癌症內科治療國衛院之臨床試驗誌.
|
陳立宗 ; Chen;Li-tzong |
